Despite remarkable economic growth in recent years, China’s reputation for intellectual property rights has been viewed as non-existent because of the perception the nation’s legal system lacked workable remedies. Recently that has begun to change, as Chinese companies won large awards for infringements of their patents. According to the Chinese State Intellectual Property Office, last year marked a turning point for enforcement in China.
Ling Zhong, Intellectual Property Associate in the New York office, examines recent developments in the intellectual property rights arena in China. Citing important examples that have contributed to the trend, she also provides an overview of patent law there. In addition to the increase in patent filings, there has also been an increase in civil cases. She suggests multinational companies develop a China-specific strategy for their innovative technologies and products.
Dr. Zhong, who has a Ph.D. in biochemistry, has a broad range of experience in intellectual property matters, with a focus on counseling, patent prosecution, due diligence investigations, licensing, and litigation in the biotechnology, pharmaceutical, and medical device areas. In particular, she has represented well-established pharmaceutical companies in ANDA litigation and the world’s leading companies in IP enforcement in China.
To read the article, please go here.
More information on Dr. Zhong is available here.